Kangmei Pharma reported 103 in PE Price to Earnings for its fiscal quarter ending in September of 2024.

Pe Change Date
Cspc Pharmaceutical 10.3 0.62 Sep/2024
Genomma Lab Internacional 19.7 4.76 Sep/2024
Hypermarcas 9.88 0.75 Jun/2024
Ionis Pharmaceuticals 539.57 0 Jun/2024
IQVIA Holdings 25.78 3.11 Sep/2024
Jiangsu Hengrui 60.81 5.87 Sep/2024
Kangmei Pharma 103 13.45 Sep/2024
Moderna 35.86 0 Sep/2024
Organon & Co 2.96 1.96 Sep/2024
Revvity 79.84 26.56 Sep/2024
Sh Fosun Pharma 40.69 11.17 Sep/2024
Tectonic Therapeutic 4.01 0.63 Mar/2024
Viatris 238.8 0 Sep/2024
Wuxi Apptec 20 1.96 Sep/2024
Zz Pientze Pharmaceu 42.02 10.34 Sep/2024